Sandbox: sadaf: Difference between revisions
Jump to navigation
Jump to search
Line 45: | Line 45: | ||
|- | |- | ||
! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic disorders | ! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Hematologic disorders | ||
! align="center" style="background:#DCDCDC;" |[[Myelodysplastic syndrome (patient information)|Myelodysplastic syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Myelodysplastic syndrome (patient information)|Myelodysplastic syndrome]] | ||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* [[Bone marrow]] infiltration | * [[Bone marrow]] infiltration | ||
Line 94: | Line 94: | ||
*Might transformed to [[acute leukemia]] | *Might transformed to [[acute leukemia]] | ||
|- | |- | ||
! align="left" style="background:#DCDCDC;" |Malignancies such as: | ! align="left" style="background:#DCDCDC;" |Malignancies such as: | ||
* [[Acute leukemia]] | * [[Acute leukemia]] | ||
* [[Chronic leukemia]] | * [[Chronic leukemia]] | ||
Line 141: | Line 141: | ||
*[[Disseminated intravascular coagulation|DIC]] | *[[Disseminated intravascular coagulation|DIC]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Myelofibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Myelofibrosis]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Bone marrow infiltration | * Bone marrow infiltration | ||
Line 161: | Line 161: | ||
| align="center" style="background:#F5F5F5;" + |Nl | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |− | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*[[Muscle weakness|Weakness]] | *[[Muscle weakness|Weakness]] | ||
Line 188: | Line 188: | ||
* May progress to malignancy | * May progress to malignancy | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Fanconi anemia]] | ! align="center" style="background:#DCDCDC;" |[[Fanconi anemia]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Genetic defect | |||
* Bone marrow failure | |||
| align="center" style="background:#F5F5F5;" + |− | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + |− | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |− | |||
| align="center" style="background:#F5F5F5;" + |Rare [[autosomal recessive]] genetic disorder, higher in Ashkenazi Jews and Afrikaners in South Africa | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Family history of [[Fanconi anemia]] | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Short stature | |||
* Petechiae and bruises | |||
* Pallor | |||
* Skin discoloration | |||
| align="center" style="background:#F5F5F5;" + |− | |||
| align="center" style="background:#F5F5F5;" + |+ | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |− | |||
| align="center" style="background:#F5F5F5;" + |− | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Skeletal defects | |||
* Deafness | |||
* VSD | |||
* Kidney abnormalities | |||
* | |||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + |↓ | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*[[Pancytopenia]] | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* [[Pancytopenia]] | |||
*Hypercellular [[bone marrow]] | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |Nl | |||
| align="center" style="background:#F5F5F5;" + |Genetic studies | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Progress to [[Acute myeloid leukemia|acute myelogenous leukemia]] | |||
* [[Neoplasm|Solid tumors]] | |||
* [[Developmental abnormality|Developmental abnormalities]] | |||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ||
Line 244: | Line 263: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Aplastic anemia]] | ! align="center" style="background:#DCDCDC;" |[[Aplastic anemia]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*Unknown | *Unknown | ||
Line 286: | Line 305: | ||
*[[Preleukemia]] | *[[Preleukemia]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Paroxysmal nocturnal hemoglobinuria]] | ! align="center" style="background:#DCDCDC;" |[[Paroxysmal nocturnal hemoglobinuria]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
*Deficiency of [[complement]] regulatory proteins | *Deficiency of [[complement]] regulatory proteins | ||
Line 331: | Line 350: | ||
*[[Aplastic anemia]] | *[[Aplastic anemia]] | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Disseminated intravascular coagulation]] | ! align="center" style="background:#DCDCDC;" |[[Disseminated intravascular coagulation]] | ||
| align="center" style="background:#F5F5F5;" + |Consumption | | align="center" style="background:#F5F5F5;" + |Consumption | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 358: | Line 377: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Dyskeratosis congenital/telomere biology disorders | ! align="center" style="background:#DCDCDC;" |Dyskeratosis congenital/telomere biology disorders | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 385: | Line 404: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Shwachman-Diamond syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Shwachman-Diamond syndrome]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 443: | Line 462: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[SLE]] | ! align="center" style="background:#DCDCDC;" |[[SLE]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 470: | Line 489: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Felty's syndrome|Felty syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Felty's syndrome|Felty syndrome]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 497: | Line 516: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Wiskott-Aldrich syndrome|Wiskott Aldrich syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Wiskott-Aldrich syndrome|Wiskott Aldrich syndrome]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 524: | Line 543: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[GATA2]] deficiency | ! align="center" style="background:#DCDCDC;" |[[GATA2]] deficiency | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 551: | Line 570: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Hemophagocytic lymphohistiocytosis]] | ! align="center" style="background:#DCDCDC;" |[[Hemophagocytic lymphohistiocytosis]] | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 579: | Line 598: | ||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI disorders | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |GI disorders | ||
! align="center" style="background:#DCDCDC;" |[[Portal hypertension]]/[[cirrhosis]] | ! align="center" style="background:#DCDCDC;" |[[Portal hypertension]]/[[cirrhosis]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Splenomegally | * Splenomegally | ||
Line 607: | Line 626: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Glycogen storage disease|Storage diseases]] (eg, [[Gaucher's disease|Gaucher]]) | ! align="center" style="background:#DCDCDC;" |[[Glycogen storage disease|Storage diseases]] (eg, [[Gaucher's disease|Gaucher]]) | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Splenomegaly | * Splenomegaly | ||
Line 666: | Line 685: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Sepsis]] | ! align="center" style="background:#DCDCDC;" |[[Sepsis]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Bone marrow infiltration | * Bone marrow infiltration | ||
Line 694: | Line 713: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Infection|Viral infection]] such as [[Human Immunodeficiency Virus (HIV)|HIV]], [[hepatitis]], [[Epstein Barr virus|Epstein-Barr virus]] | ! align="center" style="background:#DCDCDC;" |[[Infection|Viral infection]] such as [[Human Immunodeficiency Virus (HIV)|HIV]], [[hepatitis]], [[Epstein Barr virus|Epstein-Barr virus]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Marrow suppression | * Marrow suppression | ||
Line 724: | Line 743: | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nutritional | ||
! align="center" style="background:#DCDCDC;" |[[Macrocytic anemia|Megaloblastic anemia]] | ! align="center" style="background:#DCDCDC;" |[[Macrocytic anemia|Megaloblastic anemia]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Ineffective hematopoiesis | * Ineffective hematopoiesis | ||
Line 752: | Line 771: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Excessive [[alcohol]] | ! align="center" style="background:#DCDCDC;" |Excessive [[alcohol]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Ineffective hematopoiesis | * Ineffective hematopoiesis | ||
Line 780: | Line 799: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Other nutritional deficiency such as [[copper deficiency]], [[zinc]] toxicity | ! align="center" style="background:#DCDCDC;" |Other nutritional deficiency such as [[copper deficiency]], [[zinc]] toxicity | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Ineffective hematopoiesis | * Ineffective hematopoiesis | ||
Line 808: | Line 827: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Malnutrition]] | ! align="center" style="background:#DCDCDC;" |[[Malnutrition]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Ineffective hematopoiesis | * Ineffective hematopoiesis | ||
Line 837: | Line 856: | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Medications | ||
! align="left" style="background:#DCDCDC;" |Medications such as: | ! align="left" style="background:#DCDCDC;" |Medications such as: | ||
* [[Chemotherapy|Cytotoxic drugs]] | * [[Chemotherapy|Cytotoxic drugs]] | ||
* Idiosyncratic reactions to medications | * Idiosyncratic reactions to medications |
Revision as of 18:13, 12 September 2018
Differentiating Pancytopenia from Other Diseases
- There are no other mimickers of pancytopenia, as the diagnosis can be unequivocally established by laboratory testing (complete blood count).
Category | Condition | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | |||||||||||||||||||||||
Lab Findings | ||||||||||||||||||||||||||
Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | ||||||||||||||
Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Plt | HB | WBC | |||||||||||||||||||||
Hematologic disorders | Myelodysplastic syndrome |
|
+ | + | − | ± | + | Elderly | Exposure to | + | + | Nl | + | + | ↓ | ↓ | ↓ |
|
|
Nl | Nl | Nl | Bone marrow examination + clinical manifestation |
| ||
Malignancies such as: |
|
+ | + | + | ± | ± | Any, more in adults |
|
+ | + | Nl | + | − | ↓ | ↓ | ↓ |
|
↑ | ↑ | Bone marrow examination |
| |||||
Myelofibrosis |
|
+ | + | − | + | + | Average 60 years old |
|
|
+ | + | Nl | + | − | ↓ | ↓ | ↓ |
|
↑ | ↑ | Bone marrow examination |
| ||||
Fanconi anemia |
|
− | + | − | + | − | Rare autosomal recessive genetic disorder, higher in Ashkenazi Jews and Afrikaners in South Africa |
|
|
− | + | Nl | − | − |
|
↓ | ↓ | ↓ |
|
Nl | Nl | Nl | Genetic studies | |||
Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings | |
Aplastic anemia |
|
− | + | − | ± | ± | Biphasic (the young and the elderly) |
|
− | + | Nl | − | − | ↓ | ↓ | ↓ |
|
|
↑ | ↑ | Nl | Bone marrow examination +
laboratory findings |
||||
Paroxysmal nocturnal hemoglobinuria |
|
+ | + | − | − | + | Any age
(usually younger adults) |
|
|
− | − | Nl | − | − |
|
↓/Nl | ↓ | ↓/Nl |
|
Nl | Nl | Flow cytometry | ||||
Disseminated intravascular coagulation | Consumption | |||||||||||||||||||||||||
Dyskeratosis congenital/telomere biology disorders | ||||||||||||||||||||||||||
Shwachman-Diamond syndrome | + | |||||||||||||||||||||||||
Immunology/
Rheumatology |
Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings |
SLE | ||||||||||||||||||||||||||
Felty syndrome | ||||||||||||||||||||||||||
Wiskott Aldrich syndrome | + | |||||||||||||||||||||||||
GATA2 deficiency | + | |||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis | + | |||||||||||||||||||||||||
GI disorders | Portal hypertension/cirrhosis |
|
||||||||||||||||||||||||
Storage diseases (eg, Gaucher) |
|
+ | + | |||||||||||||||||||||||
Infections | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings |
Sepsis |
|
|||||||||||||||||||||||||
Viral infection such as HIV, hepatitis, Epstein-Barr virus |
|
+ | + | |||||||||||||||||||||||
Nutritional | Megaloblastic anemia |
|
+ | |||||||||||||||||||||||
Excessive alcohol |
|
|||||||||||||||||||||||||
Other nutritional deficiency such as copper deficiency, zinc toxicity |
|
|||||||||||||||||||||||||
Malnutrition |
|
|||||||||||||||||||||||||
Medications | Medications such as:
|
|
+ | |||||||||||||||||||||||
Category | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Gold standard | Associated findings |